Our prior studies have suggested that it could reactivate latent HIV by inducing both NF-κB and P-TEFb signaling pathways 38 and meanwhile inhibit HIV infection by down-regulating the expression of cell surface HIV co-receptors CCR5 and CXCR4 39in vitro. The gene discussed is CCR5; the disease is HIV infectious disease.